KAREN PARKER: Open Payments
NPI 1982910824 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 22 payments from 12 companies in 2025. Trend: 2023 $628 · 2024 $455 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $147 |
| PFIZER INC. | 4 | $92 |
| Novo Nordisk Inc | 4 | $69 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| ABBVIE INC. | 1 | $24 |
| Neurelis, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: FARXIGA, PREVNAR 20, Rybelsus, TRELEGY ELLIPTA, AIRSUPRA, VRAYLAR, VALTOCO, AREXVY.
Industry payments across LA — which companies pay providers there.
